can be found in abstracts presented here (ok, it's actually 1 1/2 years old, but it's new to me and this thread):
http://www.ornl.gov/TechResources/Human_Genome/publicat/02santa/lowdose_infra.html(unfortunately, it doesn't appear the full work has been published, or the research is in a preliminary stage, so the following information should be taken with a grain of salt, so to speak)
here's one of the several abstracts:
Efforts to sequence the human genome and to make this information available to the scientific community are already paying great dividends. New genomics data and technology make it possible to address important societal issues in biology, medicine, and even in health risk. One application has been to apply these techniques to determine the cellular and molecular responses induced by low doses of ionizing radiation.
Before the genome project, it was not possible to determine biological responses to very low levels of ionizing radiation (below about 0.10 Gy). The Low Dose Radiation Research Program funded by the DOE Office of Biological and Environmental Research was made possible by the merging of new technological developments with the genome research.
The overall goal of this program is to provide a sound scientific basis for radiation protection standards. The program has been in place for just over three years and is currently funding 54 projects. There have already been several major breakthroughs resulting in a re-evaluation of basic radiation paradigms on which current radiation risk standards were set. These breakthroughs are a direct result of the gene chip and sequencing technology generated by the genome program. There is now evidence that cells do not require a direct “hit” to exhibit changes in gene expression, gene mutation and chromosome damage, but may also respond if a neighbor cell is irradiated, a phenomenon called the “bystander” effects. Such observations make it necessary for us to re-evaluate the effective biological target size for radiation and the significance of the long held “hit theory” of radiation biology. It has also been demonstrated that exposure of the matrix on which cells grow can change both the pattern of gene expression and the cells phenotype to result in cell transformation without direct induction of mutations. Therefore, the relative role of mutations and gene expression in cancer induction must be redefined. This may result in potential impacts on the basic linear-no-threshold hypothesis that is used in standard setting.
Finally, low dose studies have demonstrated that the pattern and type of genes expressed after low doses of radiation are different from those observed after higher doses. Research has also shown that these patterns of gene expression influence many important genes involved in repair of DNA damage, as well as in programmed cell death (apoptosis). Results of recent studies suggest that low doses of radiation may decrease the level of spontaneous cell transformation resulting in another expression of the “adaptive response”. Without the advances in genomics most of these observations would not have been possible. Their impact on radiation risk and standards remains to be determined. However, the research from the Low Dose Program will provide a sound scientific basis for radiation risks. Continued application of new equipment, methods and techniques will be important in addressing many important scientific and societal needs.
other abstracts describe specific studies where low doses of radiation were found to affect the expression of hundreds of genes - the next step is to figure out if these are protective or harmful genes.